S&P 500   3,841.47 (-0.30%)
DOW   30,996.98 (-0.57%)
QQQ   325.42 (-0.29%)
AAPL   139.07 (+1.61%)
MSFT   225.95 (+0.44%)
FB   274.50 (+0.60%)
GOOGL   1,892.56 (+0.45%)
AMZN   3,292.23 (-0.45%)
TSLA   846.64 (+0.20%)
NVDA   548.50 (-1.12%)
BABA   258.62 (-0.53%)
CGC   33.80 (+0.72%)
GE   11.11 (+0.36%)
MU   82.28 (-3.21%)
AMD   92.79 (+1.38%)
NIO   61.95 (+6.19%)
T   28.93 (+0.35%)
F   11.52 (-0.09%)
ACB   10.65 (-4.66%)
BA   205.84 (-0.76%)
DIS   172.78 (+0.88%)
NFLX   565.17 (-2.53%)
GILD   66.94 (-0.06%)
S&P 500   3,841.47 (-0.30%)
DOW   30,996.98 (-0.57%)
QQQ   325.42 (-0.29%)
AAPL   139.07 (+1.61%)
MSFT   225.95 (+0.44%)
FB   274.50 (+0.60%)
GOOGL   1,892.56 (+0.45%)
AMZN   3,292.23 (-0.45%)
TSLA   846.64 (+0.20%)
NVDA   548.50 (-1.12%)
BABA   258.62 (-0.53%)
CGC   33.80 (+0.72%)
GE   11.11 (+0.36%)
MU   82.28 (-3.21%)
AMD   92.79 (+1.38%)
NIO   61.95 (+6.19%)
T   28.93 (+0.35%)
F   11.52 (-0.09%)
ACB   10.65 (-4.66%)
BA   205.84 (-0.76%)
DIS   172.78 (+0.88%)
NFLX   565.17 (-2.53%)
GILD   66.94 (-0.06%)
S&P 500   3,841.47 (-0.30%)
DOW   30,996.98 (-0.57%)
QQQ   325.42 (-0.29%)
AAPL   139.07 (+1.61%)
MSFT   225.95 (+0.44%)
FB   274.50 (+0.60%)
GOOGL   1,892.56 (+0.45%)
AMZN   3,292.23 (-0.45%)
TSLA   846.64 (+0.20%)
NVDA   548.50 (-1.12%)
BABA   258.62 (-0.53%)
CGC   33.80 (+0.72%)
GE   11.11 (+0.36%)
MU   82.28 (-3.21%)
AMD   92.79 (+1.38%)
NIO   61.95 (+6.19%)
T   28.93 (+0.35%)
F   11.52 (-0.09%)
ACB   10.65 (-4.66%)
BA   205.84 (-0.76%)
DIS   172.78 (+0.88%)
NFLX   565.17 (-2.53%)
GILD   66.94 (-0.06%)
S&P 500   3,841.47 (-0.30%)
DOW   30,996.98 (-0.57%)
QQQ   325.42 (-0.29%)
AAPL   139.07 (+1.61%)
MSFT   225.95 (+0.44%)
FB   274.50 (+0.60%)
GOOGL   1,892.56 (+0.45%)
AMZN   3,292.23 (-0.45%)
TSLA   846.64 (+0.20%)
NVDA   548.50 (-1.12%)
BABA   258.62 (-0.53%)
CGC   33.80 (+0.72%)
GE   11.11 (+0.36%)
MU   82.28 (-3.21%)
AMD   92.79 (+1.38%)
NIO   61.95 (+6.19%)
T   28.93 (+0.35%)
F   11.52 (-0.09%)
ACB   10.65 (-4.66%)
BA   205.84 (-0.76%)
DIS   172.78 (+0.88%)
NFLX   565.17 (-2.53%)
GILD   66.94 (-0.06%)
Log in
OTCMKTS:GLUC

Glucose Health Stock Forecast, Price & News

$6.27
-0.15 (-2.34 %)
(As of 01/22/2021 12:00 AM ET)
Add
Compare
Today's Range
$5.90
Now: $6.27▼
$6.50
50-Day Range
$2.77
MA: $5.12▼
$8.70
52-Week Range
$0.07
Now: $6.27▼
$8.98
Volume37,786 shs
Average Volume151,622 shs
Market Capitalization$72.91 million
P/E RatioN/A
Dividend YieldN/A
Beta3.54
Glucose Health, Inc. manufactures and sells dietary supplements for persons with pre-diabetes and/or Type-2 diabetes. Its principal product is Glucose Health, a dietary supplement formulated from nine natural ingredients to have a beneficial impact upon blood glucose, triglyceride, and cholesterol levels. Glucose Health, Inc. sells its product through national and regional pharmacy retailers, as well as through its Website, glucosehealth.com. The company was formerly known as Bio-Solutions Corp. and changed its name to Glucose Health, Inc. in November 2014. Glucose Health, Inc. was incorporated in 2007 and is based in Bentonville, Arkansas.

MarketRank™

Overall MarketRank™

0.00 out of 5 stars

Medical Sector

1831st out of 1,922 stocks

Medicinals & Botanicals Industry

32nd out of 33 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Medicinals & botanicals
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:GLUC
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.glucosehealthinc.com
Phone479-802-3827
EmployeesN/A

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$290,000.00
Price / Sales251.41
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$-250,000.00
Net Margins-136.46%
Return on EquityN/A
Return on Assets-199.60%

Miscellaneous

Outstanding Shares11,628,000
Market Cap$72.91 million
Next Earnings Date2/1/2021 (Estimated)
OptionableNot Optionable
$6.27
-0.15 (-2.34 %)
(As of 01/22/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive GLUC News and Ratings via Email

Sign-up to receive the latest news and ratings for GLUC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Glucose Health (OTCMKTS:GLUC) Frequently Asked Questions

What stocks does MarketBeat like better than Glucose Health?

Wall Street analysts have given Glucose Health a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Glucose Health wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Glucose Health's next earnings date?

Glucose Health is scheduled to release its next quarterly earnings announcement on Monday, February 1st 2021.
View our earnings forecast for Glucose Health.

Are investors shorting Glucose Health?

Glucose Health saw a increase in short interest in the month of December. As of December 31st, there was short interest totaling 8,400 shares, an increase of 75.0% from the December 15th total of 4,800 shares. Based on an average trading volume of 66,400 shares, the days-to-cover ratio is presently 0.1 days.
View Glucose Health's Short Interest.

Who are some of Glucose Health's key competitors?

Some companies that are related to Glucose Health include Charlie's (CHUC), MediWound (MDWD), Natural Alternatives International (NAII), True Drinks (TRUU), Happiness Biotech Group (HAPP), FSD Pharma (HUGE), Mannatech (MTEX), Tauriga Sciences (TAUG), Cyanotech (CYAN), FitLife Brands (FTLF), Nutra Pharma (NPHC), Exactus (EXDI), Heyu Biological Technology (HYBT), GLG Life Tech (GLGLF) and Entia Biosciences (ERGO).
View all of GLUC's competitors.

What other stocks do shareholders of Glucose Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Glucose Health investors own include Two Harbors Investment (TWO), Celsius (CELH), Flaherty & Crumrine Total Return Fund (FLC), Annaly Capital Management (NLY), NVIDIA (NVDA), Pinterest (PINS), PayPal (PYPL), Brookfield Real Assets Income Fund (RA), Tesla (TSLA) and Apollo Global Management (APO).

Who are Glucose Health's key executives?

Glucose Health's management team includes the following people:
  • Mr. Murray S. Fleming, CEO, CFO & Director (Age 57)
  • Ms. Sarah Berman CPA, Advisor of Accounting
  • Ms. Peggy Knight, Advisor of Marketing & Branding (Age 64)
  • Mr. William J. Gallagher, Advisor to the Board (Age 81)
  • Dr. Chandrasekhar Mallangi, Advisor of Nutrition Science

What is Glucose Health's stock symbol?

Glucose Health trades on the OTCMKTS under the ticker symbol "GLUC."

How do I buy shares of Glucose Health?

Shares of GLUC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Glucose Health's stock price today?

One share of GLUC stock can currently be purchased for approximately $6.27.

How big of a company is Glucose Health?

Glucose Health has a market capitalization of $72.91 million and generates $290,000.00 in revenue each year.

What is Glucose Health's official website?

The official website for Glucose Health is www.glucosehealthinc.com.

How can I contact Glucose Health?

Glucose Health's mailing address is 609 SW 8TH STREET 6TH FLOOR, BENTONVILLE AR, 72712. The company can be reached via phone at 479-802-3827 or via email at [email protected]

This page was last updated on 1/22/2021 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.